DalsnaFinance › Analyst accuracy › Argus Research › AMGN target
Argus Issues Positive Forecast for Amgen (NASDAQ:AMGN) Stock Price
Argus upped their price target on Amgen from $375.00 to $460.00 and gave the stock a "buy" rating in a report on Wednesday.
A fact about what Argus Research published, as reported by MarketBeat, not a recommendation from Dalsna Finance; Argus Research is not affiliated with this site.
Full methodology: how targets are collected, scored, ranked and corrected, what each field means, and how to cite the data.